{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:08:40Z","timestamp":1781147320317,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01776"],"award-info":[{"award-number":["PI14\/01776"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS15\/00166"],"award-info":[{"award-number":["DTS15\/00166"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01055"],"award-info":[{"award-number":["PI15\/01055"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Retic","award":["RD012\/0021\/0032"],"award-info":[{"award-number":["RD012\/0021\/0032"]}]},{"name":"Retic","award":["RD16\/0009\/0025"],"award-info":[{"award-number":["RD16\/0009\/0025"]}]},{"name":"REDINREN-FEDER"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2013-45784-R"],"award-info":[{"award-number":["SAF2013-45784-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["IPT-2012-0779-010000"],"award-info":[{"award-number":["IPT-2012-0779-010000"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellence Group","award":["GR100"],"award-info":[{"award-number":["GR100"]}]},{"name":"Consejer\u00eda de Sanidad","award":["BIO\/SA87\/13"],"award-info":[{"award-number":["BIO\/SA87\/13"]}]},{"name":"Consejer\u00eda de Sanidad","award":["BIO\/SA15\/14"],"award-info":[{"award-number":["BIO\/SA15\/14"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.taap.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T15:37:39Z","timestamp":1524065859000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["N -acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity"],"prefix":"10.1016","volume":"349","author":[{"given":"Sandra M.","family":"Sancho-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Prieto-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fuentes-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"L\u00f3pez-Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mart\u00ednez-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.04.010_bb0005","first-page":"35","article-title":"Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance","volume":"2","author":"Andrews","year":"1990","journal-title":"Cancer Cells"},{"key":"10.1016\/j.taap.2018.04.010_bb0010","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/S0021-9258(18)83116-7","article-title":"Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria","volume":"264","author":"Broekemeier","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.04.010_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2017.04.015","article-title":"Key role of oxidative stress in animal models of aminoglycoside nephrotoxicity revealed by a systematic analysis of the antioxidant-to-nephroprotective correlation","volume":"385","author":"Casanova","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.04.010_bb0020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/dmd.30.12.1378","article-title":"Kinetic study of the reaction of cisplatin with thiols","volume":"30","author":"Dabrowiak","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.04.010_bb0025","first-page":"417","article-title":"Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells","volume":"7","author":"Dolman","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.taap.2018.04.010_bb0030","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ki.1991.269","article-title":"Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity","volume":"40","author":"Dos Santos","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2018.04.010_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00280-002-0540-5","article-title":"Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig","volume":"51","author":"Ekborn","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2018.04.010_bb0040","doi-asserted-by":"crossref","first-page":"F1632","DOI":"10.1152\/ajprenal.00422.2009","article-title":"Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation","volume":"297","author":"Feldkamp","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2018.04.010_bb0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ki.2010.439","article-title":"Urinary levels of regenerating islet-derived protein III \u0392 and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats","volume":"79","author":"Ferreira","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2018.04.010_bb0050","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc300020f","article-title":"Peptide-drug conjugate linked via a disulfide bond for kidney targeted drug delivery","volume":"23","author":"Geng","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.taap.2018.04.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-5-32","article-title":"A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity","volume":"5","author":"Gonzales","year":"2007","journal-title":"BMC Med."},{"key":"10.1016\/j.taap.2018.04.010_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2014.03.002","article-title":"Selective ETA receptor blockade protects against cisplatin-induced acute renal failure in male rats","volume":"730","author":"Helmy","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2018.04.010_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0009-2797(80)90122-2","article-title":"Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA","volume":"30","author":"Johnson","year":"1980","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2018.04.010_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","article-title":"Mechanisms of resistance to cisplatin","volume":"478","author":"Kartalou","year":"2001","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.taap.2018.04.010_bb0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00775-008-0456-6","article-title":"Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts","volume":"14","author":"Kasherman","year":"2009","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.taap.2018.04.010_bb0080","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1248\/bpb.33.1867","article-title":"Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity","volume":"33","author":"Katsuda","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2018.04.010_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MNH.0b013e32831daf54","article-title":"Tubuloglomerular feedback mechanisms in nephron segments beyond the macula densa","volume":"18","author":"Komlosi","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.taap.2018.04.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1159\/000142935","article-title":"Antioxidants: do they have a place in the prevention or therapy of acute kidney injury?","author":"Koyner","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.taap.2018.04.010_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4196\/kjpp.2008.12.4.149","article-title":"Expression of endothelin-1 and its receptors in cisplatin-induced acute renal failure in mice","volume":"12","author":"Lee","year":"2008","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2018.04.010_bb0100","first-page":"F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.taap.2018.04.010_bb0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2013.02.001","article-title":"Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine","volume":"167","author":"Lin","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2018.04.010_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.cdd.4401329","article-title":"Retinoid-related molecules require caspase 9 for the effective release of Smac and the rapid induction of apoptosis","volume":"11","author":"Lopez-Hernandez","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2018.04.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2018.04.010_bb0120","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/ndt\/gfn090","article-title":"The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats","volume":"23","author":"Luo","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.taap.2018.04.010_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI1497","article-title":"Induction of p21(WAF1\/CIP1\/SD11) in kidney tubule cells affects the course of cisplatin-induced acute renal failure","volume":"101","author":"Megyesi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2018.04.010_bb0130","article-title":"Efficacy of N-acetylcysteine in preventing acute kidney injury after cardiac surgery: a meta-analysis study","volume":"1\u201310","author":"Mei","year":"2017","journal-title":"J. Investig. Surg."},{"key":"10.1016\/j.taap.2018.04.010_bb0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathyby a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2018.04.010_bb0140","first-page":"309","article-title":"Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity","volume":"6","author":"Muldoon","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2018.04.010_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-014-1657-1","article-title":"N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models","volume":"121","author":"Muldoon","year":"2015","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.taap.2018.04.010_bb0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1124\/jpet.103.063347","article-title":"Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model","volume":"309","author":"Neuwelt","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2018.04.010_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/biof.5520340208","article-title":"Lipid peroxidation products as oxidative stress biomarkers","volume":"34","author":"Niki","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.taap.2018.04.010_bb0160","doi-asserted-by":"crossref","first-page":"F378","DOI":"10.1152\/ajprenal.00192.2003","article-title":"Protection of renal cells from cisplatin toxicity by cell cycle inhibitors","volume":"286","author":"Price","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2018.04.010_bb0165","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.2010.267","article-title":"Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein","volume":"78","author":"Quiros","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2018.04.010_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/dmd.30.2.183","article-title":"Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs","volume":"30","author":"Sadowitz","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.04.010_bb0175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/10408444.2011.602662","article-title":"An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity","volume":"41","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2018.04.010_bb0180","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1093\/ndt\/gfr195","article-title":"Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity","volume":"26","author":"Sanchez-Gonzalez","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.taap.2018.04.010_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/toxsci\/kfr098","article-title":"Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis","volume":"122","author":"Sancho-Mart\u00ednez","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.04.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2012.07.003","article-title":"Subcellular targets of cisplatin cytotoxicity: an integrated view","author":"Sancho-Mart\u00ednez","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.04.010_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfv069","article-title":"Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury","author":"Sancho-Mart\u00ednez","year":"2015","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.taap.2018.04.010_bb0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/15376516.2011.568985","article-title":"Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats","volume":"21","author":"Shalby","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2018.04.010_bb0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0891-5849(03)00470-2","article-title":"Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells","volume":"35","author":"Shino","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2018.04.010_bb0210","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1242\/jcs.093575","article-title":"Die another way--non-apoptotic mechanisms of cell death","volume":"127","author":"Tait","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.taap.2018.04.010_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10495-015-1190-5","article-title":"Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity","volume":"21","author":"Trist\u00e3o","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.taap.2018.04.010_bb0220","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1681\/ASN.2014080741","article-title":"A role for tubular necroptosis in cisplatin-induced AKI","volume":"26","author":"Xu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2018.04.010_bb0225","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s10495-007-0110-8","article-title":"Involvement of both tumor necrosis factor-\u03b1-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin","volume":"12","author":"Yano","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.taap.2018.04.010_bb0230","first-page":"173","article-title":"Preventing cisplatin induced ototoxicity by N-acetylcysteine and salicylate","volume":"20","author":"Yildirim","year":"2010","journal-title":"Kulak Burun Bogaz Ihtis Derg."},{"key":"10.1016\/j.taap.2018.04.010_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/lary.24360","article-title":"Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients","author":"Yoo","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.taap.2018.04.010_bb0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000354463","article-title":"Mitochondria-targeted antioxidant peptide SS31 prevents hypoxia\/reoxygenation-induced apoptosis by down-regulating p66Shc in renal tubular epithelial cells","volume":"32","author":"Zhao","year":"2013","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18301467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18301467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:43:15Z","timestamp":1660966995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18301467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":48,"alternative-id":["S0041008X18301467"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.04.010","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}